Infectious Disease News Alerts have dropped into my inbox now, for nearly a decade. This organisation is run by a company called "SLACK Incorporated, and "strives to be the global, definitive information source for ID professionals by delivering timely, accurate, authoritative and balanced reports on clinical issues, socioeconomic topics and industry developments, as well as presenting clinically relevant information on medical therapies for the benefit of the patient." Of course, that's followed by the usual disclaimer saying words to the effect of "believe us at your peril".
There is this caveat here: "All staff-written news reports are sent to quoted sources for verification of medial accuracy. Quotes and other information in staff-written news reports are verified for accuracy with sources prior to publication. Excluded from this policy are InfectiousDiseaseNews.com website-first articles, which are not sent to sources to facilitate the rapid dissemination of this news."
Just before that, is stated, "All articles posted on InfectiousDiseaseNews.com are reviewed by the Chief Medical Editor and Executive Editor, who are solely responsble for deciding upon their acceptance, rejection, or need for revision, based upon their appropriateness to the mission of the publication."
So while two people must review all articles, the buck stops with Chief Editor, Dr Paul A Volberding, Go hunting for his particulars and you see this. And given that,"Dr. Volberding serves as scientific advisor to Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Ortho Biotech, Pfizer/Agouron, Shire, and Schering; and on the speakers bureau for Gilead, GlaxoSmithKline, Ortho Biotech, and Schering." .... you would think he would understand the term "accuracy", right?
Apparently not, because this week InfectiousDiseaseNews Alerts posted an article, which is solely his responsibility, which heralded the news that HPV Vaccines prevent anal cancer in women (pdf of news item, since I'd be surprised if it's not pulled.) The article states:
There were 27 diagnosed HPV 16-related anal cancers in the vaccine group vs. 85 diagnoses in the control group, for a vaccine efficacy of 68.2% (95% CI, 51.4-79.7). For cervical cancer, researchers observed 28 diagnoses in the vaccine group compared with 116 in the control group. Vaccine efficacy against cervical HPV 16 was 75.8% (95% CI, 63.8-84.2).
For HPV 18, there were 20 diagnosed anal cancers in the vaccine group compared with 45 in the control group. Vaccine efficacy was 55.5% (95% CI, 25.2-74.2). Thirteen vaccinated patients were diagnosed with cervical cancer vs. 61 in the control group. Vaccination efficacy against cervical HPV 18 infection was 78.6% (95% CI, 62-88.7).
So let's check this out shall we? Kreimer's article, starts with this statement: "Anal cancer remains rare (Incidence of about 1.5 per 100,000 women yearly)."
So two people should have read Kreimer's article, ... the first sentence raises the first red flag. Given that Kreimer's study included just over 4,000 women, if according the Kreimer there are 1.5 anal cancers in 100,000 women per year, how many would you expect in 4,000?
Read further and you find that this study was about INFECTIONS, not actual CANCERS. Read the article very carefully and you will see many reasons why Kreimer's article really doesn't deserve a news item in Infectious Diseases News at all, but having ascribed virtues to the vaccine, which the study did not...., Dr Volberding needs a disciplinary reminder. With his CV, he should know better. And talking about his CV, note that (coincidentally) Volberding approved an untrue article about a vaccine, made by a company whose payroll he is on. Hmmm........ Read Full Blog